48-week data from the study of adalimumab in children with juvenile rheumatoid arthritis (JRA)N. Ruperto,D. J. Lovell,S. Goodman,A. Reiff,L. Jung,D. Nemcova,K. Jarosova,A. Prieur, C. Sanborg,R. Joos, I. Foeldari,V. Gerloni,J. Rovensky,J. Bohnsack,K. Minden,L. Wagner Weiner,R. Vehe, H. Kuppertz,G. Horneff,N. Olson,J. Medich,E. H. Giannini,A. MartiniANNALS OF THE RHEUMATIC DISEASES(2006)引用 0|浏览9暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要